Plasma Concentrations of Estramustine Phosphate and Its Major Metabolites in Patients with Prostatic Carcinoma Treated with Different Doses of Estramustine Phosphate (Estracyt®).
Authors:
- 1 January 1981
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 15 (3) , 201-206
Abstract
Plasma concentrations of estramustine phosphate and its major metabolites were measured in patients with prostatic carcinoma treated with increasing oral doses, 70-560 mg/day, of estramustine phosphate (Es-tracyt®). Parent drug and estradiol were measured by radioimmunoassay, and estramustine and its estrone analogue (Leo 271) utilizing gas chromatography. The concentrations of estramustine phosphate and estramustine were below or close to the limits of the methods. A linear correlation was found between the daily dose of estramustine phosphate, and plasma concentrations of Leo 271—the main metabolite—and estradiol, which suggests that no capacity limiting processes are involved in the pharmacokinetics of estramustine phosphate in man. Plasma was also analyzed during prolonged treatment with 560 mg/day. The metabolite pattern was not changed by two to three years of estramustine phosphate treatment.Keywords
This publication has 10 references indexed in Scilit:
- Metabolism of estramustine phosphate (Estracyt ®) in patients with prostatic carcinomaEuropean Journal of Drug Metabolism and Pharmacokinetics, 1981
- Hormonal Effects of Different Doses of Estramustine Phosphate (Estracyt®) in Patients with Prostatic CarcinomaScandinavian Journal of Urology and Nephrology, 1981
- Estramustine Phosphate: Metabolic Aspects Related to Its Action in Prostatic CancerJournal of Urology, 1978
- Estramustine Phosphate: A Specific Chemotherapeutic Agent?Journal of Urology, 1977
- Treatment of Advanced Carcinoma of the Prostate with Estramustine PhosphateBritish Journal of Urology, 1977
- Estramustine Phosphate Therapy in Carcinoma of the Prostate1977
- Treatment of Advanced Prostatic Carcinoma with Estramustine Phosphate (Estracyt®)Scandinavian Journal of Urology and Nephrology, 1977
- Extended Therapy of Stage D Carcinoma of the Prostate with Oral Estramustine PhosphateJournal of Urology, 1976
- Studies on Phenolic Steroids in Human Subjects. XIV. Fate of a Nitrogen Mustard of Estradiol-17βThe Journal of Clinical Endocrinology & Metabolism, 1975
- Radioimmunoassay method for six steroids in human plasmaSteroids, 1973